Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-544.44%
↓ 3621% below average
Average (39q)
15.46%
Historical baseline
Range
High:1068.18%
Low:-544.44%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -544.44% |
| Q2 2025 | 112.86% |
| Q1 2025 | 22.22% |
| Q4 2024 | 50.00% |
| Q3 2024 | -5.88% |
| Q2 2024 | 15.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 4.76% |
| Q3 2023 | 4.55% |
| Q2 2023 | -37.50% |
| Q1 2023 | 0.00% |
| Q4 2022 | -14.29% |
| Q3 2022 | 17.65% |
| Q2 2022 | -6.25% |
| Q1 2022 | 5.88% |
| Q4 2021 | -6.25% |
| Q3 2021 | -23.08% |
| Q2 2021 | 13.33% |
| Q1 2021 | -234.08% |
| Q4 2020 | -105.83% |
| Q3 2020 | 218.46% |
| Q2 2020 | -3.17% |
| Q1 2020 | -31.25% |
| Q4 2019 | -122.54% |
| Q3 2019 | 1068.18% |
| Q2 2019 | -4.76% |
| Q1 2019 | -31.25% |
| Q4 2018 | 38.46% |
| Q3 2018 | 21.21% |
| Q2 2018 | 17.50% |
| Q1 2018 | -48.15% |
| Q4 2017 | 6.90% |
| Q3 2017 | 12.12% |
| Q2 2017 | 0.00% |
| Q1 2017 | -6.45% |
| Q4 2016 | 11.43% |
| Q3 2016 | 5.41% |
| Q2 2016 | -8.82% |
| Q1 2016 | -140.48% |
| Q4 2015 | 347.06% |